<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Sawyer TK</submitter><funding>NIDDK NIH HHS</funding><funding>NIGMS NIH HHS</funding><pubmed_abstract>Sphingolipid activator protein B (saposin B; SapB) is an essential activator of globotriaosylceramide (Gb3) catabolism by α-galactosidase A. However, the manner by which SapB stimulates α-galactosidase A activity remains unknown. To uncover the molecular mechanism of SapB presenting Gb3 to α-galactosidase A, we subjected the fluorescent substrate globotriaosylceramide-nitrobenzoxidazole (Gb3-NBD) to a series of biochemical and structural assays involving SapB. First, we showed that SapB stably binds Gb3-NBD using a fluorescence equilibrium binding assay, isolates Gb3-NBD from micelles, and facilitates α-galactosidase A cleavage of Gb3-NBD &lt;i>in vitro&lt;/i>. Second, we crystallized SapB in the presence of Gb3-NBD and validated the ligand-bound assembly. Third, we captured transient interactio</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2024.04.04.584535</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11014568</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Human Saposin B Ligand Binding and Presentation to α-Galactosidase A.</pubmed_title><pmcid>PMC11014568</pmcid><funding_grant_id>P30 GM133894</funding_grant_id><funding_grant_id>R01 DK076877</funding_grant_id><pubmed_authors>Garman SC</pubmed_authors><pubmed_authors>Staros JV</pubmed_authors><pubmed_authors>Bobst CE</pubmed_authors><pubmed_authors>Aral E</pubmed_authors><pubmed_authors>Sawyer TK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human Saposin B Ligand Binding and Presentation to α-Galactosidase A.</name><description>Sphingolipid activator protein B (saposin B; SapB) is an essential activator of globotriaosylceramide (Gb3) catabolism by α-galactosidase A. However, the manner by which SapB stimulates α-galactosidase A activity remains unknown. To uncover the molecular mechanism of SapB presenting Gb3 to α-galactosidase A, we subjected the fluorescent substrate globotriaosylceramide-nitrobenzoxidazole (Gb3-NBD) to a series of biochemical and structural assays involving SapB. First, we showed that SapB stably binds Gb3-NBD using a fluorescence equilibrium binding assay, isolates Gb3-NBD from micelles, and facilitates α-galactosidase A cleavage of Gb3-NBD &lt;i>in vitro&lt;/i>. Second, we crystallized SapB in the presence of Gb3-NBD and validated the ligand-bound assembly. Third, we captured transient interactio</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-05-27T08:04:10.047Z</modification><creation>2026-05-27T03:07:56.564Z</creation></dates><accession>S-EPMC11014568</accession><cross_references><pubmed>38617236</pubmed><doi>10.1101/2024.04.04.584535</doi></cross_references></HashMap>